Improve Immunogenicity, Delivery & CMC of mRNA Cancer Vaccines Towards Accelerated Discovery, Translation & Clinical Development of Next Generation Cancer Treatments for Patients
October 10-12, 2023 | Boston, MA
Welcome to the mRNA Cancer Vaccine Summit: Bringing Novel & Effective mRNA Cancer Vaccines to Patients Faster
The mRNA Cancer Vaccine Summit 2023 comes to Boston as the community is on the cusp of something truly exciting. This is the first and only forum dedicated to showcasing mRNA cancer vaccine technology advances, translational insights and critical clinical updates from the global leaders working towards effective harnessing of neoantigens and developing successful tailor-made mRNA cancer vaccines. Unite with mRNA cancer vaccine, oncology and immune-oncology leaders and stay up to date about these innovative cancer therapies. With individualized neoantigen therapies showing critical promise in the clinic, neoantigen leaders unite to exhibit a whole-day dedicated to neoantigen discovery and identification, towards optimized discovery and development of personalized cancer vaccines to differentiate and fast track your pipelines
Reconsider the Manufacturing Challenges & Supercharge into the Approaches to Produce a Successful Neoantigen Individualized Cancer Vaccine
Discuss the alternative sources of antigens for personalized cancer immunotherapies and review the ongoing clinical trials using lipopolyplex? formulated mRNA cancer vaccines with insights from Evaxion BioTech & StemiRNA
Optimize the Immunogenicity of mRNA Cancer Vaccines: Maximizing Effectiveness & Minimizing Side Effects in Cancer Treatment
Explore the latest advances and novel technologies towards improved immunogenicity and reduced toxicity of your mRNA cancer vaccine candidates with insights from NeoMatrix & HDT Bio
Benchmarking the Next Generation of mRNA Technologies as Alternative Candidate for Use in Cancer Vaccines
Understand how self-amplifying RNA, circular RNA and silencing RNA all have potential to overcome the existing challenges within cancer vaccines with insights from CancerVax & Strand Therapeutics
Uncover Methods for Improved Assessment of Immune Biomarkers & Stability of mRNA Cancer Vaccines to Guarantee High Quality & Efficient Vaccines
Investigate the key factors for biomarkers discovery and how to ensure the stability of your mRNA molecule during production and storage with insights from Gritstone Bio & RVAC Medicine
Explore the Latest Clinical Data & How to Design Better Clinical Trials to Develop More Effective Vaccines
Uncover the latest clinical data on mRNA cancer vaccines candidates and review future innovations in the oncology treatment landscape with insights from Genentech & Moderna
Expert Speakers Include:
Proud to Partner With
